• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Roth MKM Maintains Buy Rating and Set Target Price for Tenax Therapeutics
14:09
Piper Sandler Analyst Maintains Buy Rating on Tenax Therapeutics
11:52
Tenax Therap released FY2025 Q3 earnings on November 12, 2025, EST: Actual Revenue USD 0 (Forecast USD 0), Actual EPS USD -0.4 (Forecast USD -1.124)
04:00
Tenax Therap released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -0.9562
04:00
Aug14
Tenax Therap released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -0.558
03:00
Tenax Therap released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2741 (forecast USD -0.4475)
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -15.8 M, EPS -0.3976

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -10.85 M, EPS -0.2741

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.41 M, EPS -0.2844

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More